Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

In2Bones

Explore full profile

Innovative french company specialising in the design and manufacture of medical devices intended for use in surgery

Memphis, United StatesFounded 2011Health Tech & Medtech
Valuation $100–500M Latest valuation · 2022
Revenue $10–50M Latest reported FY
Headcount <100 Current team size
Total funding $0–10M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for In2Bones and the history behind them.

About In2Bones

In2Bones SAS operates within the medical device sector, specifically focusing on extremity orthopedics for upper and lower limbs. The company was established in 2018 in Ecully, near Lyon, France. Its foundation is the result of a collaboration between a team of engineers and respected surgeons in the field. This partnership aims to develop and market implants and instruments for bone surgery, particularly for hands, feet, and ankles.

Read full description

The business model centers on the design, manufacturing, and distribution of these specialized orthopedic devices. In2Bones serves healthcare professionals, including orthopedic surgeons and hospitals, providing them with the necessary tools for various surgical procedures. The company generates revenue through the sale of its product portfolio to this client base. The market is the global orthopedic extremity segment, with a significant presence in France and the United States through its subsidiary, In2Bones USA, based in Memphis, Tennessee.

The product line includes a range of implants such as screws, plates, and nails, as well as associated instrumentation designed for precision and ease of use in surgery. For instance, the company offers specific solutions like the AlloAid PIP for finger joint fusions and the CoLink View Mfx for midfoot fracture plating systems. A key aspect of their product development is the emphasis on sterile-packaged, single-use instrument kits. This approach aims to improve operating room efficiency, reduce the risk of surgical site infections, and provide cost-effective solutions for healthcare facilities by eliminating the need for reprocessing.

Source: Dealroom company data

At a glance

Founded
2011
Headquarters
Memphis, United States
Sector
Health Tech & Medtech
Power Law
Colt$25–100M revenue

Latest news

Press, funding announcements and product moves mentioning In2Bones.

See all news

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Andera Partners
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇺🇸 United States72.5%
🇫🇷 France23.2%
🇨🇦 Canada1.4%
🇧🇪 Belgium1.4%
🇮🇪 Ireland1.4%
5 countries shown
Web traffic by country
20 monthly visits
across markets
🇩🇪 Germany0%
Top 1 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about In2Bones on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See In2Bones on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.